Minor Cannabinoids Guide: CBN, CBG, and CBC Explained

Minor Cannabinoids Guide: CBN, CBG, and CBC Explained

Beyond the well-known THC and CBD, cannabis plants produce dozens of minor cannabinoids with unique therapeutic potential. This guide covers three of the most promising: CBN (cannabinol), CBG (cannabigerol), and CBC (cannabichromene).

What Is CBN (Cannabinol)?

Cannabinol (CBN) is a non-psychoactive cannabinoid that forms when THC degrades through exposure to heat, air, and light in aged cannabis plants. CBN demonstrates weak binding affinity for CB1 receptors but stronger affinity for CB2 receptors.

CBN Potential Benefits

• Sleep support: Limited research suggests sedative properties, though only one 1975 study definitively examined this claim
• Pain relief: Preclinical animal studies indicate CBN may dramatically decrease muscle sensitization
• Anti-inflammatory: Research on mice showed potential for reducing allergen-induced mucus production
• Additional benefits: Appetite stimulation, neuroprotection, and antibacterial properties

What Is CBG (Cannabigerol)?

Cannabigerol (CBG) is often called the “mother of all cannabinoids” because its acidic form (CBGA) serves as the precursor to other cannabinoids like CBD and THC through decarboxylation. Young cannabis plants typically contain only 1% CBG by weight. CBG interacts with both CB1 and CB2 receptors and is believed to enhance anandamide activity.

CBG Potential Benefits

• Neuroprotective properties: Animal studies show improved motor function and preserved striatal function with robust antioxidant activity
• Anti-inflammatory effects: Demonstrated benefits for inflammatory bowel disease and cognitive function
• Antibacterial properties: Shows activity against MRSA and other harmful bacteria
• Additional benefits: Potential relief from anxiety, pain, nausea, and appetite stimulation

CBG vs CBD

Unlike THC, CBG produces no euphoric or mind-altering effects. While CBD research is more extensive, emerging studies suggest CBG may enhance CBD’s effectiveness for certain inflammatory conditions.

What Is CBC (Cannabichromene)?

Cannabichromene (CBC) is a non-psychoactive cannabinoid discovered over 60 years ago. Unlike THC and CBD, CBC does not directly bind to brain cannabinoid receptors. Instead, it interacts with TRPV1 and TRPA1 receptors linked to pain perception, enhancing the effects of other cannabinoids through the entourage effect.

CBC Potential Benefits

• Anti-inflammatory and pain relief: Binds to CB2 receptors and activates pain-perception-related receptors
• Mental health support: Studies demonstrate antidepressant and anxiolytic effects in animal models
• Brain health: Positively impacts neural stem progenitor cells that maintain brain homeostasis
• Anticancer properties: Animal studies indicate CBC may inhibit new cancer cell growth

Comparison Table

Available Products

All three minor cannabinoids are available as gummies, tinctures, capsules, and topicals. Full-spectrum CBD products typically contain trace amounts of CBN, CBG, and CBC, contributing to the entourage effect.

Safety Considerations

Research on human effects of these minor cannabinoids remains limited. Potential side effects include drowsiness (especially CBN), dry mouth, dizziness, and fatigue. All three may interact with medications metabolized by liver enzymes. Consult a healthcare provider before use, and always select lab-tested products from reputable vendors.